Skip to main content

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable?

Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections.

At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision.

In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight.

The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is delayed, the condition can lead to the loss of vision, and in some cases increase mortality.

MUCORMYCOSIS


WHAT IS MUCORMYCOSIS?

According to the US Centre for Diseases Control and Prevention (CDC), mucormycosis or black fungus is a rare fungal infection. But mucormycosis (previously called zygomycosis) is a serious infection caused by a group of molds or fungi called mucormycetes. These molds live throughout the environment.

It most commonly affects the sinuses or the lungs after inhaling fungal spores from the air. It can also occur on the skin after a cut, burn, or other type of skin injury.

WHEN DO SYMPTOMS APPEAR?

The symptoms of mucormycosis or black fungus appear two-three days after a person has recovered from the Covid-19 infection.

This fungal infection first occurs in the sinus after the patient is cured of Covid-19 and in about two-four days, it invades the eyes, ENT specialist Dr Sanket Shah of Kiran Hospital in Surat explained.

In the next 24 hours, the black fungus can travel up to the brain.

WHO IS MORE VULNERABLE?

Dr Sanket Shah said the fungal infection attacks people with weak immunity. Among the worst affected are those with uncontrolled sugar levels (diabetic people) and people who have health problems or take medicines that lower the body's ability to fight germs and sickness.

According to Dr Ajay Swaroop, the chairman of the ENT department at the Kiran Hospital, the infection is commonly seen in patients who have recovered from Covid-19 but have comorbidities such as diabetes, kidney or heart failure or cancer.

SYMPTOMS OF MUCORMYCOSIS AKA BLACK FUNGUS

Excruciating headache and redness in the eyes are two of the common symptoms of mucormycosis.

General symptoms of rhinocerebral (sinus and brain) mucormycosis include:

  • One-sided facial swelling
  • Headache
  • Nasal or sinus congestion
  • Black lesions on nasal bridge or upper inside of mouth that quickly become more severe
  • Fever

Symptoms of pulmonary (lung) mucormycosis include:

  • Fever
  • Cough
  • Chest pain
  • Shortness of breath
  • Cutaneous (skin) mucormycosis can look like blisters or ulcers, and the infected area may turn black. Other symptoms include pain, warmth, excessive redness, or swelling around a wound.

Symptoms of gastrointestinal mucormycosis include:

  • Abdominal pain
  • Nausea and vomiting
  • Gastrointestinal bleeding

BLACK FUNGUS OUTSIDE SURAT

Dr Manish Munjal, senior ENT surgeon at the Sir Ganga Ram Hospital said, "We are seeing a rise again in this dangerous fungal infection triggered by Covid-19. In the last two days, we have admitted six cases of mucormycisis.

"Last year, this deadly infection caused high mortality with many patients suffering from the loss of eyesight and the removal of the nose and the jawbone."

Dr Ajay Swaroop, the chairman of the ENT department at the hospital, said the use of steroids in the treatment of Covid-19 coupled with the fact that many coronavirus patients have diabetes could be one of the reasons for ths rise in the number of black fungus cases again.


News Source : https://www.indiatoday.in/coronavirus-outbreak/story/black-fungus-mucormycosis-detected-covid19-survivors-8-lose-eyesight-surat-fungal-infection-symptoms-1799971-2021-05-07

Comments

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...